How a Moldy Cantaloupe Took Fleming’s Penicillin from Discovery to Mass Production
Alexander Fleming’s 1928 discovery of a mold with antibacterial properties was only the first serendipitous event on the long road to penicillin as a life-saving drug.
How a Moldy Cantaloupe Took Fleming’s Penicillin from Discovery to Mass Production
How a Moldy Cantaloupe Took Fleming’s Penicillin from Discovery to Mass Production
Alexander Fleming’s 1928 discovery of a mold with antibacterial properties was only the first serendipitous event on the long road to penicillin as a life-saving drug.
Alexander Fleming’s 1928 discovery of a mold with antibacterial properties was only the first serendipitous event on the long road to penicillin as a life-saving drug.
Infrastructure expansion will enable rapid ingestion, homogenization of new multi-omics and real-world data for accelerated delivery of multidimensional insights to inform drug development
Claudia Lopez-Lloreda, PhD | Oct 23, 2024 | 4 min read
Inhibiting a protein isoform in the spinal cord alongside morphine improves the opioid’s pain-relieving properties without increasing unwanted side effects.
Kevin Fitzgerald from Alnylam Pharmaceuticals explains the potential of RNA interference for treating disease and highlights recent clinical trial successes.
The extended agreement will expand the dedicated bioconjugation footprint for the customer through the construction of a new bioconjugation suite at Lonza’s Ibex® Biopark in Visp (CH).
Advanced microscopy aided in the detection of the pathogen responsible for a nationwide superworm apocalypse and informed the development of a potential vaccine strategy.
This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.
Constructed using low-drug-absorbing plastics, Chip-R1 builds upon the core microfluidic design of Organ-Chips, offering researchers greater precision in predicting human drug responses.